Desktop Site
|
25 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
74,339.44
+486.50
+0.66 %
Corporate Announcement
Security Code
532296
Company
GLENMARK PHARMACEUTICALS LTD.
Exchange Disseminated Time
Q3 results on Feb 02, 2017 |
1/17/2017 6:47:55 PM
Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors will be held on February 02, 2017, to consider and approve the Company's Unaudited Financial Statements for the Third Quarter and Nine months ended December 31, 2016 (Q3).
Further, as per the "Code of Conduct for Prevention of Insider Trading" and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Company has intimated its Directors and other designated persons regarding the closure of trading window from December 26, 2016 to February 06, 2017 (both days inclusive) for the purpose of approval of Unaudited Financial Statements for the Third Quarter and Nine months ended December 31, 2016.
<< Back
Recently Viewed